quick and easy portfolio data delivery
New regulations require regular reconciliation of all OTC derivative portfolios. With triResolve QuickPort, TriOptima now offers a safe and effective way for non-subscribers to respond to portfolio requests from OTC derivatives counterparties at no cost.
Designed to eliminate email and other unsecure means of portfolio delivery to multiple counterparties, data is uploaded to the secure triResolve QuickPort site manually or via automated file transfer for reconciliation. triResolve QuickPort delivers a summary of the results, indicating where differences exist with counterparties.
triResolve QuickPort is offered free of charge upon signing a mutual Non-Disclosure Agreement with TriOptima.
triResolve vs. triResolve QuickPort
While triResolve QuickPort offers a secure and efficient way to upload portfolios and view summary reconciliation results, regular subscribers to the triResolve exposure management service enjoy the full range of service benefits.
|Leverage existing file formats|
|Low-touch IT involvement|
|Single point portfolio submission to counterparties|
|Secure portfolio submission to counterparties|
|Proactive Portfolio Reconciliation|
|Immediate online access to network community|
|Real-time view of unresolved exceptions|
|Smart matching for portfolio reconciliation|
|Resolve discrepancies via exception management workflow|
|Repository Validation and Reconciliation|
|Validate and reconcile internal books and records against repository data|
|Reconcile across trade repositories without the need for a UTI/USI|
|Highlights differences across all reported fields|
|Identify & investigate sources of disputes|
|Monitor dispute resolution process / send notifications|
|Summary report of reconciliation results|
|Advanced analytics and fully flexible MI reporting|
Interest Rate Trade Reporting Repository
Terms and Conditions for Access and Use
1. Scope of Agreement
2. Intellectual property rights, license to use
3. Prohibited use of Reports
4. Non-reliance, no warranty, disclaimer
Without prejudice to the above, TriOptima shall not be liable to you, or anyone claiming under or through you, for loss of profit, or any indirect or consequential loss or damages under or in connection with this Agreement, the use of any Report or this website, including without limitation, damages for loss of capital, interest, revenue, data or use, or interruption of business, even if you had been advised of the possibility of such damages.
5. Viruses, malware
6. Applicable law, disputes
I agree I decline
Please fill in the form below and you will receive instructions on how to get up and running on triResolve QuickPort in just a few easy steps
I have read and understood the Terms & Conditions
Thank you for your interest in triResolve QuickPort.
To begin the NDA download, please click here
You can get up and running in a few easy steps:
Step 1: Sign and return downloaded standard Confidentiality Agreement (NDA).
Detailed instructions accompany the NDA.
Step 2: Our Service Management Team will contact you to provide access to our triResolve
QuickPort website and give you instructions on how to upload your data.
Step 3: Upload your portfolio data to the website (batch or manually).
In your own preferred data format (converted by triResolve Service Management into standard format).
Step 4: Access your summary reconciliation results on the website as often as you or
your counterparties provide new portfolio data.
With triResolve QuickPort, you can set up an STP process to reconcile your OTC derivatives portfolios with our large community of counterparties who currently use triResolve, including all of the global dealers. Once you are up and running you will experience all the benefits of triResolve QuickPort:
Please do not hesitate to contact TriOptima if you have any further questions, either by calling your regional TriOptima office or sending an e-mail to firstname.lastname@example.org.
We look forward to working with you on triResolve QuickPort.
New York +1 646 744 0400
London +44 20 7382 2200
Stockholm +46 8 545 25 130
Singapore +65 6372 8181
Tokyo +81 3 6450 1350